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Background: ER-stress associated with cerebral 
ischemia induces the expression of the 
transcription factor CHOP. 
Results: Interaction with CHOP downregulates 
cell surface GABAB receptors and thus GABAB 
receptor-mediated neuronal inhibition. 
Conclusion: Interaction of CHOP with GABAB 
receptors in the ER prevents forward trafficking of 
the receptors. 
Significance: This mechanism is expected to 
contribute to excitotoxicity in cerebral ischemia. 
 
ABSTRACT 
Cerebral ischemia frequently leads to long-term 
disability and death. Excitotoxicity is believed 
to be the main cause for ischemia-induced 
neuronal death. Although a role of glutamate 
receptors in this process has been firmly 
established, the contribution of metabotropic 
GABAB receptors, which control excitatory 
neurotransmission, is less clear. A prominent 
characteristic of ischemic insults is endoplasmic 
reticulum (ER) stress associated with the up-
regulation of the transcription factor CHOP. 
After inducing ER stress in cultured cortical 
neurons by sustained Ca
2+
-release from 
intracellular stores or by a brief episode of 
oxygen and glucose deprivation (OGD, in vitro 
model of cerebral ischemia), we observed an 
increased expression of CHOP accompanied by 
a strong reduction of cell surface GABAB 
receptors. Our results indicate that down-
regulation of cell surface GABAB receptors is 
caused by the interaction of the receptors with 
CHOP in the ER. Binding of CHOP prevented 
heterodimerization of the receptor subunits 
GABAB1 and GABAB2 and subsequent forward 
trafficking of the receptors to the cell surface. 
The reduced level of cell surface receptors 
diminished GABAB receptor signaling and thus 
neuronal inhibition. These findings indicate that 
ischemia-mediated up-regulation of CHOP 
downregulates cell surface GABAB receptors by 
preventing their trafficking from the ER to the 
plasma membrane. This mechanism leads to 
diminished neuronal inhibition and may 
contribute to excitotoxicity in cerebral ischemia.  
 
 GABAB receptors are Gi/o protein coupled 
receptors composed of the two obligatory and 
functionally distinct subunits GABAB1 and 
GABAB2. GABAB1 harbors the binding site for 
orthosteric ligands while GABAB2 contains a 
binding site for allosteric modulators, recruits the 
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G protein and is required for trafficking of the 
receptors from the endoplasmic reticulum (ER) to 
the plasma membrane (reviewed in (1)). GABAB1 
contains an ER retention signal in the C-terminal 
domain, which retains unassembled GABAB1 in 
the ER. Heterodimerization with GABAB2 masks 
the ER retention signal and permits ER export of 
the receptor heterodimers (2-4). GABAB receptors 
are abundantly expressed throughout the 
mammalian central nervous system where they 
mediate slow and persistent inhibition. According 
to their prominent role in regulating neuronal 
excitability, GABAB receptors have been 
implicated in a variety of neurological disorders 
including cerebral ischemia. 
 In cerebral ischemia, excessive glutamatergic 
neurotransmission eventually leads to neuronal 
death (5). Decreased GABAergic activity appears 
to contribute to neuronal overexcitation (6) and 
there are indications that GABAB receptors are 
down-regulated under ischemic conditions (7-10). 
This suggests that impaired GABAB receptor 
signaling contributes to excitotoxicity. In line with 
these findings, enhancing GABAB receptor activity 
during ischemic insults by application of the 
GABAB receptor agonist baclofen has been 
reported to be neuroprotective in vitro and in vivo 
(10-19).  
 Cerebral ischemia induces ER stress, which is 
characterized by the accumulation of proteins in 
the ER, leading to the activation of several 
pathways to restore normal ER function (20). If, 
however, ER function is severely impaired and 
cellular homeostasis cannot be restored, apoptosis 
of the neuron is induced. ER stress triggers the 
activation and expression of a number of proteins, 
including up-regulation of the transcription factor 
CHOP (C/EBP-homologous protein, also known as 
C/EBPζ, growth arrest- and DNA damage-
inducible gene 153 [GADD153] or DNA-damage 
inducible transcript 3 [DDIT3]). CHOP belongs to 
the C/EBP transcription factor family and has been 
shown to trigger apoptosis (21). 
 Besides its function as a transcription factor, 
there is evidence that CHOP interacts with GABAB 
receptors to regulate their cell surface expression. 
We previously showed that CHOP interacts with 
its C-terminal leucine zipper with the leucine 
zipper present in the C-terminal domain of 
GABAB2 and with its N-terminal domain with an 
as yet unidentified site in GABAB1 (22). Upon 
coexpression in HEK 293 cells, CHOP induced the 
intracellular accumulation of GABAB receptors 
and a significant reduction of cell surface receptors 
(22). However, the mechanism behind this down-
regulation of cell surface receptors as well as its 
physiological role remained unclear. Because 
ischemic conditions cause ER stress and 
upregulates CHOP we aimed in the present study 
at elucidating the mechanism of CHOP-induced 
down-regulation of cell surface GABAB receptors 
in neurons and its putative role in cerebral 
ischemia. We found that ER stress-induced CHOP 
interacts with GABAB receptors in the ER to 
disrupt GABAB receptor heterodimerization. This 
prevents forward trafficking of the receptors to the 
plasma membrane and thus leads to the down-
regulation of cell surface receptors and reduced 
GABAB receptor signaling. This mechanism is 
operative in an in vitro model of cerebral ischemia.  
 
EXPERIMENTAL PROCEDURES 
 Antibodies – The following primary antibodies 
were used: rabbit GABAB1a,b directed against the 
C-terminus of GABAB1  and rabbit GABAB1b 
directed against the N-terminus of GABAB1b 
(affinity-purified, 1:200 for immunofluorescence, 
1:40 for in situ PLA; custom made by GenScript) 
(23) as well as rabbit GABAB2 directed against the 
N-terminus of GABAB2 (24) (affinity-purified, 
1:500 for immunofluorescence, 1:40 for in situ 
PLA; custom made by GenScript), guinea pig 
GABAB2 (1:50; Chemicon International, # 
AB5394), rabbit GABAA receptor 1 subunit (25) 
(affinity purified 1:100 for in situ PLA), mouse 
GABAA receptor 2/3 subunits (25) (1:500 for in 
situ PLA), mouse GADD153/CHOP (1:100, Santa 
Cruz Biotechnology, # sc-7351), mouse 
GADD153/CHOP (1:100 for immunofluorescence, 
1:30 for in situ PLA; Cell Signaling Technology, # 
2895), rabbit Anti-MAP Kinase (ERK-1, ERK-2, 
1:500; Sigma Aldrich, # M5670), mouse Anti-
MAP Kinase Activated (diphosphorylated ERK-
1&2, 1:250; Sigma Aldrich, # M9692), rabbit 
NeuN (1:500; Millipore AG, # ABN78), goat PDI 
(1:150; Santa Cruz Biotechnology, # sc-17222), 
mouse GM130 (1:1000; Abcam, # ab32337), 
rabbit HA (1:200; Santa Cruz Biotechnology, # sc-
805), rabbit c-myc (1:500; Santa Cruz 
Biotechnology, # sc-789). Secondary antibodies 
were either coupled to Alexa Fluor 488 (1:1000, 
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Invitrogen), Cy-3 (1:500, Jackson 
ImmunoResearch) or Cy-5 (1:300, Jackson 
ImmunoResearch).  
 Plasmids – Plasmids containing full-length 
cDNA of human CHOP and deletion mutants of 
CHOP (C-terminal deletion (ΔLZ) and N-terminal 
deletion (ΔN)) were described previously (22). 
Plasmids containing wild type and mutant rat 
GABAB1 and rat GABAB2 were kindly provided by 
Bernhard Bettler (University of Basel, Switzerland) 
and described in (3). 
 Drugs – The following drugs were used: 
thapsigargin (1 µM; Sigma Aldrich), (R)-baclofen 
(100 µM; Tocris Bioscience), CPG 56999A (10 
µM; gift from Novartis, Basel, Switzerland).  
 Cell culture – Primary cortical neurons were 
prepared from E18 embryos of time-pregnant 
Wistar rats as described previously (26). Briefly, 
minced E8 cortex was incubated for 15 min with 
papain solution (0.5 mg/ml PBS, 1 mg/ml BSA, 10 
mM glucose, 10 µg/ml DNaseI), washed with 
Dulbecco’s modified Eagle’s Medium containing 
10% fetal calf serum and titruated using a Pasteur 
pipette. Neurons were plated at a density of 
120,000 cells onto poly-L lysine coverslips (12 
mm) in 24-well plates and kept in culture at 37°C 
and 5% CO2 for 11-15 days. 
Neurons in neuron-glia co-cultures were 
transfected with plasmids using magnetofection 
exactly as described in (27). 60,000 cells were 
plated on 18 mm coverslips and kept in culture for 
11-15 days at 37°C and 5% CO2. Magnetofection 
was performed for 30 min on a pre-warmed 
magnetic plate.  
 Immunocytochemistry and Confocal Laser 
Scanning Microscopy – Multiplex-labeling 
immunocytochemistry was performed as described 
previously (26). For the visualization of cell 
surface GABAB receptors, living neurons were 
incubated with primary antibodies for 2 h at 4°C in 
ACSF (2 mM CaCl2, 2 mM MgCl2, 30 mM L-
glucose, 5 mM KCl, 119 mM NaCl, 25 mM 
HEPES, pH 7.4) containing 10% NGS (Normal 
Goat Serum). For staining of intracellular localized 
proteins, neurons were subsequently fixed with 4% 
paraformaldehyde for 15 min at room temperature 
and permeabilized for 6 min with 0.2 % Triton X-
100. Neurons were then incubated with primary 
antibodies for 1 h (in PBS/10% NGS) at room 
temperature, washed four times for 5 min with 
PBS and incubated with secondary antibodies for 1 
h. After four washes with PBS neurons were 
mounted in fluorescence mounting medium and 
analyzed by confocal laser scanning microscopy 
(LSM510 Meta; Zeiss). Images were acquired 
using a Zeiss 100x plan apochromat oil differential 
interference contrast objective (1.4 NA) at 
512x512 pixel resolution for fluorescence intensity 
measurements or 1024x1024 pixel resolution for 
colocalization studies. For each neuron, 5 optical 
sections spaced by 0.4 µm were taken.  
 Fluorescence intensity measurements were 
performed using the Mac Biophotonics ImageJ 
software (version 1.41n). For analysis of cell 
surface protein expression, cells were carefully 
outlined and mean fluorescence intensity of the 
soma was subtracted. For total protein expression 
analysis, somata of neurons were carefully 
outlined and the mean intensity of the fluorescence 
signals was measured. An area of each image 
containing no specific signals was selected for 
determining background staining and was 
subtracted from the image.  
 Colocalization studies were performed using 
Imaris (version 7.1.1, Bitplane, Zurich, 
Switzerland). Images were smoothed using the 
median filter tool (filter size: 3x3x1) and further 
processed by setting threshold cutoffs for each 
channel to exclude background staining. 
Colocalization channels were built (colocalization 
intensity 255, constant value) and protein clusters 
(>15 pixels) as well as colocalized clusters were 
counted within a randomly selected 30 µm
2
 area of 
the somata. 
 Gene expression assays – GABAB1, GABAB2 
and CHOP RNA levels were determined in cortical 
primary neurons using real-time PCR. Total RNA 
was extracted from neurons using the GenElute 
Mammalian Total RNA Miniprep Kit (Sigma 
Aldrich) according to the manufactures 
recommendations. Reverse transcription was 
performed with the QuantiTec Reverse 
Transcription Kit (Quiagen). Quantitative real-time 
PCR (7900HT Fast Real-Time PCR System; 
Applied Biosciences) was done using the prepared 
cDNA and TaqMan Gene Expression Assays 
(Applied Biosciences) for GABAB1 (Gabbr1, 
Assay ID Rn00578911_m1), GABAB2 (Gabbr2, 
Assay ID Rn00582550_m1), CHOP (Ddit3, Assay 
ID Rn00492098_g1) and -actin (Actb, Assay ID 
Mm00607939_s1) as a control. Quantification of 
RNA levels was done using the ΔΔCt method.  
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 Baclofen-Induced ERK1/2 Phosphorylation – 
GABAB receptor activity was indirectly 
determined by measuring the levels of baclofen-
induced ERK1/2 phosphorylation (28-31). Cortical 
neurons were incubated with the GABAB receptor 
agonist baclofen for 10 min at 37 °C, 5% CO2 or 
were left untreated for controls. Subsequently, the 
cultures were placed on ice, fixed with 4% 
paraformaldehyde for 15 min at 4°C and 
permeabilized with 0.2 % Triton X-100 for 6 min. 
For determination of ERK1/2 phosphorylation, 
cultures were incubated overnight at 4°C with 
antibodies directed against total ERK1/2 as well as 
with antibodies against diphosphorylated ERK1/2. 
After washing with PBS, secondary antibodies 
were added for 1h at room temperature and 
neurons were analyzed by measuring fluorescence 
intensities of total and diphosphorylated ERK1/2 
levels using confocal laser scanning microscopy. 
Levels of phosphorylated ERK1/2 were normalized 
to total ERK1/2 levels. Specificity of the baclofen-
induced ERK1/2 phosphorylation was determined 
using the GABAB receptor antagonist CPG 
56999A. 
 In situ proximity ligation assay (in situ PLA) – 
The in situ PLA is a highly sensitive antibody-
based method for the visualization of protein-
protein interactions and postranslational 
modification in cultured cells and tissue section 
(32,33). This method employs two primary 
antibodies detecting the proteins of interest raised 
in different species and corresponding secondary 
antibodies (PLA probes) tagged with 
oligonucleotides. Only when the proteins of 
interest are in close proximity (<30 nm) specific 
connector oligonucleotides can be hybridized and 
ligated to the oligonucleotides attached to the 
secondary antibodies forming a circular 
oligonucleotide. Rolling circle amplification then 
creates a large DNA strand to which numerous 
fluorophor-labeled oligonucleotides (detection 
probes) are hybridized. This generates a bright 
fluorescent spot that can be easily detected by 
microscopy. Quantification is done by counting the 
number of spots.  
Here we used in situ PLA for analyzing the 
interaction of CHOP with GABAB receptors and 
the heterodimerization of GABAB1 and GABAB2. 
In situ PLA was performed using the Duolink Kit 
(Olink Bioscience) according the manufacturers 
protocol as described previously (34). The 
specificity of the PLA signal was verified for both 
pairs of antibodies in HEK 293 cells expressing or 
not expressing one of the interaction partners. 
Furthermore, leaving out one of the primary 
antibodies completely prevented PLA signals. For 
in situ PLA neurons were fixed and permeabilized 
as described above and incubated with primary 
antibodies (in PBS/10% NGS) overnight at 4°C. 
After in situ PLA, neurons were analyzed by 
confocal laser scanning microscopy as described 
above. Protein-protein interactions were quantified 
by counting signal dots using the ImageJ software. 
Image-stacks (5 optical sections spaced by 0.4 µm) 
of individual neurons were merged visualizing 
maximum intensities and number of maxima per 
area was determined.  
 Forward trafficking assay – For visualization 
of the amount of GABAB receptors inserted into 
the plasma membrane within a time period of 16 h, 
neurons were incubated in culture medium with 
antibodies directed against GABAB2 for 2 h at 
37°C. Following washes with ACSF to remove 
unbound primary antibody, cells were incubated 
for 2 h with a large excess of Alexa 488 
conjugated secondary antibody to label (i. e. mask) 
the existing pool of cell surface receptors. After 
washing, the neurons were further incubated in 
culture medium for 16 h at 37°C to allow 
neosynthesis of GABAB receptors and forward 
trafficking of receptors to the plasma membrane. 
Neurons were then placed on ice and stained at 
4°C for receptors newly inserted into the plasma 
membrane using antibodies directed against 
GABAB2 and Cy3-conjugated secondary 
antibodies. Neurons were then processed for 
confocal laser scanning microscopy. Controls for 
judging the efficiency of labeling (i. e. masking) 
the pool of cell surface receptors were treated in 
exactly the same but kept at 4°C for the 16 h 
incubation period.  
 Electrophysiology – Neurons of thapsigargin-
treated or untreated control cultures were recorded 
in the whole-cell voltage-clamp configuration at 
room temperature. Spontaneously occurring 
postsynaptic currents (sPSCs) were recorded 
before, during and after the application of 50 M 
baclofen at a holding potential of -60 mV. Patch 
electrodes were pulled from borosilicate glass and 
were filled with 120 mM CsCl, 10 mM EGTA, 10 
mM HEPES (pH 7.4), 4 mM MgCl2, 0.5 mM GTP 
and 2 mM ATP. The external solution contained 
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140 mM NaCl, 10 mM KCl, 2 mM CaCl2, 1 mM 
MgCl2, 10 mM HEPES pH 7.4 and 10 mM glucose. 
Recordings were performed with a HEKA EPC-7 
amplifier and Patch Master v2.11 software (HEKA 
Elektronik, Germany). Baclofen (50 μM) was 
locally applied using an outlet tube (200 m ID) of 
a custom-designed gravity-fed micro-perfusion 
system positioned 50-100 m of the recorded 
neuron. All the synaptic events displaying 
amplitudes above the background noise (5–12 pA) 
were identified and analyzed off-line using the 
MiniAnalysis 6.0.7 software (Synaptosoft). Mean 
amplitudes and frequency values were obtained 
from 1 min-long recordings for each experimental 
condition and normalized.  
 Oxygen glucose deprivation (OGD) model of 
ischemia – Primary cortical neurons were washed 
twice with DMEM without glucose or with 
DMEM containing glucose for controls. For OGD, 
neurons were incubated for 10 min at 37°C in 95% 
N2/5% CO2 pre-bubbled glucose-free DMEM in an 
airtight box filled with 95% N2/5% CO2. Control 
cultures were incubated in DMEM containing 
glucose at 37°C in a physiological oxygen-
containing environment. Subsequently, cells were 
washed twice with DMEM containing glucose and 
incubated for 24 h in their original culture medium.  
 
RESULTS 
 CHOP Interacts with GABAB Receptors and 
Downregulates Cell Surface Receptors in Neurons 
  We had previously shown that the stress-
induced transcription factor CHOP, which is only 
marginally expressed under normal physiological 
condition, interacts with GABAB receptors by 
binding to the coiled-coil motif in the C-terminal 
domain of GABAB2 and with a so far unidentified 
site in GABAB1 (22). Upon overexpression in HEK 
293 cells, interaction of CHOP with GABAB 
receptors resulted in the intracellular accumulation 
and a reduced cell surface expression of the 
receptors by an as yet unknown mechanism (22). 
To confirm an interaction of GABAB receptors 
with CHOP in neurons, we overexpressed CHOP 
in cultured cortical neurons and tested for an 
interaction with GABAB receptors using the in situ 
proximity ligation assay (in situ PLA, (32,33)). In 
non-transfected neurons only very few PLA dots 
were detected, being in line with a low expression 
level of CHOP under normal physiological 
conditions. However, overexpression of CHOP 
dramatically increased PLA signals, indicating 
numerous GABAB receptor-CHOP interactions 
(Fig. 1A). 
Because ER stress-induced up-regulation of CHOP 
has been shown to play an important role in 
ischemia-induced neuronal death (35-42) we then 
analyzed the mechanism of CHOP-induced down-
regulation of cell surface GABAB receptors by 
exposing cultured cortical neurons to ER stress. 
ER stress was induced by treating neurons for 2 h 
with the sarco/endoplasmic reticulum Ca
2+
-ATPase 
blocker thapsigargin. After a 16 h recovery period, 
neurons were analyzed for CHOP and GABAB 
receptor interaction using in situ PLA. Under 
control conditions, i. e. in untreated neurons, only 
few interactions were observed (Fig. 1B). However, 
upon up-regulation of CHOP with thapsigargin, 
numerous interactions with GABAB receptors were 
detected (454 ± 53% of control, n=30, p < 0.001, 
Fig. 1B). Thus, up-regulation of CHOP by ER 
stress resulted in an interaction with GABAB 
receptors. Under these conditions, no in situ PLA 
signals were generated using CHOP and GABAA 
receptor antibodies, documenting the specificity of 
the CHOP-GABAB receptor interaction (Fig. 1C). 
 An analysis of the protein expression levels 
revealed that CHOP was vastly up-regulated in 
thapsigargin-treated neurons (706 ± 65% of control, 
n=57, p < 0.001; Fig. 2A), whereas the cell surface 
staining of GABAB1 and GABAB2 was 
significantly decreased (GABAB1: 67 ± 4%, 
GABAB2: 50 ± 3% of control, n=50-55, p < 0.001; 
Fig. 2A). No colocalization of CHOP with cell 
surface GABAB receptors was detected. In contrast 
to cell surface receptors, total GABAB1 and 
GABAB2 expression levels remained unchanged in 
thapsigargin-treated neurons (Fig. 2B). These 
findings suggest that the interaction of CHOP with 
GABAB receptors caused a down-regulation of the 
receptors from the cell surface and their 
intracellular accumulation. 
 To verify that the loss of cell surface receptors 
was caused by the interaction of CHOP with 
GABAB receptors, neurons were transfected with 
mutant forms of CHOP that are unable to interact 
with GABAB1 (CHOPN, N-terminal deletion 
(22)) or GABAB2 (CHOPLZ, deletion of C-
terminal leucine zipper motif (22)). Neurons 
overexpressing wild type CHOP displayed a 
 at H
auptbibliothek U
niversitaet Zuerich Irchel. Bereich Forschung on M
arch 25, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 
6 
 
significantly reduced level of cell surface GABAB2 
compared to control neurons transfected with 
EGFP (63 ± 4%, n=82, p < 0.001; Fig. 2C). 
However, overexpressing either of the CHOP 
mutants did not affect cell surface expression of 
GABAB receptors (CHOPΔLZ: 92 ± 5%, p > 0.05, 
n=79; CHOPΔN: 103 ± 5%, n=101, p > 0.05), 
suggesting that down-regulation of cell surface 
receptors was based on its interaction with CHOP. 
 To rule out that up-regulation of CHOP affects 
transcription of GABAB1 and GABAB2, their 
mRNA levels were quantified in neurons treated 
with thapsigargin using real-time PCR (Fig. 2D). 
CHOP mRNA levels were drastically increased in 
thapsigargin-treated neurons (432 ± 54% of control, 
n=4, p < 0.001) but GABAB1 and GABAB2 mRNA 
levels remained unchanged (GABAB1: 113 ± 6% of 
control, n=5, p > 0.05; GABAB2: 94 ± 12% of 
control, n=5, p > 0.05). Thus, CHOP does not 
regulate GABAB receptor expression at the 
transcriptional level.  
 CHOP-Mediated Down-regulation of Cell 
Surface Receptors Reduces GABAB Receptor 
Signaling  It is well established that GABAB 
receptors activate extracellular-signal-regulated 
kinase 1/2 (ERK1/2) in neurons (28-31). To analyze 
the functional consequences of CHOP-mediated 
down-regulation of GABAB receptors, receptor 
activity was assayed based on baclofen-induced 
ERK1/2 phosphorylation. Activation of GABAB 
receptors with 100 M baclofen in control neurons 
significantly increased ERK1/2 phosphorylation 
(159 ± 10%, n=26, p < 0.001; Fig. 3A), which was 
abolished by preincubation of neurons with the 
GABAB receptor antagonist CPG 56999A (106 ± 
10%, n=26, p > 0.05; Fig. 3A). However, in 
thapsigargin-treated neurons no increase of ERK1/2 
phosphorylation was observed (108 ± 8% of 
control, n=28, p > 0.05; Fig. 3A), indicating that 
CHOP-mediated down-regulation of cell surface 
GABAB receptors inhibits downstream signaling.  
 To test whether CHOP-induced down-
regulation of GABAB receptors affects GABAB 
receptor-mediated neuronal inhibition, 
spontaneous synaptic activity was measured in 
electrophysiological experiments using the whole-
cell voltage-clamp configuration. In untreated 
control neurons, application of baclofen 
considerably decreased the amplitude (66 ± 6% of 
control, n=9) and the frequency (38 ± 8% of 
control, n=5) of spontaneous postsynaptic currents 
(sPSCs) (Fig. 3B). However, after up-regulation of 
CHOP by treating cultures with thapsigargin, 
baclofen-induced inhibition of sPSCs was strongly 
reduced (amplitude: 87 ± 6% of control n=9, p < 
0.05, frequency: 65 ± 9% of control, n=5, p < 0.05; 
Fig. 3B). This finding is consistent with an up-
regulation of CHOP and subsequently reduced 
levels of functional GABAB receptors available for 
neuronal inhibition. 
 CHOP Interacts with GABAB Receptors in the 
ER and Interferes with Receptor 
Heterodimerization – Next, we investigated the 
mechanism of CHOP-mediated down-regulation of 
cell surface GABAB receptors. We envisioned two 
scenarios: 1) CHOP disrupts functional GABAB 
receptor heterodimers on the cell surface, which 
would lead to their internalization and degradation, 
or 2) CHOP interacts with GABAB receptors in the 
ER, inhibits receptor heterodimerization and 
consequently forward transport to the cell surface. 
To test these two scenarios, we analyzed the 
colocalization of CHOP and GABAB receptor 
subunits in different cellular compartments in 
untreated control neurons and neurons treated with 
thapsigargin to upregulate CHOP. In thapsigargin-
treated neurons, GABAB receptors accumulated in 
the ER as indicated by an increased colocalization 
of GABAB1 (control: 10 ± 0.7 clusters, n=20, 
thapsigargin: 15 ± 0.8 clusters, n=21, p < 0.001) 
and GABAB2 (control: 7 ± 0.7 clusters, n=32, 
thapsigargin: 13 ± 0.7 clusters, n=32, p < 0.001) 
with the ER marker protein disulfide isomerase 
(PDI, Fig. 4A, B). Hardly any CHOP was observed 
in the ER under control conditions, whereas CHOP 
accumulated in the ER after thapsigargin treatment 
(GABAB1 stained neurons, control: 2 ± 0.4 clusters, 
n=20, thapsigargin: 9 ± 0.9 clusters, n=21, p < 
0.001; Fig. 4A; GABAB2 stained neurons, control: 
1.5 ± 0.4 clusters, n=32, thapsigargin: 9 ± 0.6 
clusters, n=32, p < 0.001; Fig. 4B). Triple-
colocalization of GABAB-CHOP-PDI was 
basically absent under control conditions but 
significantly increased after up-regulation of 
CHOP by thapsigargin (Fig. 4A, B; GABAB1-
CHOP-PDI, control: 1.4 ± 0.3 clusters, n=20, 
thapsigargin: 6 ± 0.7 clusters, n=21, p < 0.01; 
GABAB2-CHOP-PDI, control: 0.7 ± 0.3 clusters, 
n=32, thapsigargin: 6 ± 0.5 clusters, n=32, p < 
0.001). These findings indicate that GABAB 
receptors interact with CHOP in the ER, which 
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leads to the accumulation of GABAB1 and 
GABAB2 in the ER. 
 In contrast, GABAB receptors did not display 
increased colocalization with the Golgi apparatus 
marker (GM) GM130 in thapsigargin-treated 
neurons (control: 27 ± 3 clusters, n=19, 
thapsigargin: 30 ± 3 clusters, p > 0.05, n=19; Fig. 
4C), indicating no accumulation of GABAB 
receptors in the Golgi after up-regulation of CHOP. 
In line with this finding, there was no statistically 
significant increase in CHOP-GM colocalization 
control: 3 ± 1 clusters, n=19; thapsigargin: 7 ± 2 
clusters, p > 0.05, n=19, p > 0.05; Fig. 4C) nor in 
GABAB2-CHOP-GM (control: 2 ± 0.7 clusters, 
n=19, thapsigargin: 6 ± 2 clusters, n=19, p > 0.05; 
Fig. 4C), indicating marginal interactions between 
CHOP and GABAB receptors in the Golgi after 
thapsigargin-induced up-regulation of CHOP.  
 In addition, there was no significant 
colocalization of CHOP with GABAB receptors at 
the cell surface (control: 1.3 ± 0.2 clusters, n=45; 
thapsigargin: 2.3 ± 0.5 clusters, n=44, p > 0.05; 
Fig. 4D), indicating that GABAB receptors do not 
interact with CHOP in the plasma membrane.  
 To demonstrate that the accumulation of 
GABAB receptors in the ER is mediated by direct 
interaction with CHOP, we expressed in neurons a 
mutant form of GABAB2 lacking its leucine zipper 
(GABAB2ΔLZ), and thus its CHOP interaction site, 
together with GABAB1 containing a mutated ER 
retention signal (GABAB1ASA) to ensure forward 
trafficking of the receptors. GABAB1ASA was 
required because deletion of the GABAB2 leucine 
zipper unmasks the ER retention signal in the C-
terminus of GABAB1 and therefore prevents 
forward trafficking of the receptors. To verify 
normal trafficking behavior of the 
GABAB1ASA/GABAB2ΔLZ heterodimers we 
analyzed the colocalization of GABAB1ASA and 
GABAB2ΔLZ with PDI and CHOP in thapsigargin-
treated and untreated neurons. In thapsigargin-
treated neurons, GABAB1ASA
 
(control: 10 ± 3 
clusters, n=12; thapsigargin: 15 ± 5 clusters, n=19, 
p < 0.01, Fig. 5A), GABAB2 (control: 13 ± 5 
clusters, n=17; thapsigargin: 17 ± 4 clusters, n=15, 
p < 0.01, Fig. 5B) and CHOP (Fig. 5A, control: 1.3 
± 1.4 clusters, n=13, thapsigargin: 11 ± 5 clusters, 
n=20, p < 0.001; Fig. 5B, control: 1.4 ± 1.8 
clusters, n=17, thapsigargin: 11 ± 5 clusters, n=16, 
p < 0.001) showed increased colocalization with 
the ER marker PDI. Also, increased colocalization 
of GABAB1 or GABAB2 with CHOP and PDI 
(GABAB1/CHOP/PDI and GABAB2/CHOP/PDI) 
was detected in thapsigargin-treated neurons 
(GABAB1ASA, control: 0.7 ± 1.1 clusters, n=13, 
thapsigargin: 7 ± 4 clusters, n=20, p < 0.001; 
GABAB2, control: 0.8 ± 1.1 clusters, n=17, 
thapsigargin: 6 ± 3 clusters, n=16, p < 0.001; Fig. 
5A, B). The identical colocalization patterns of 
GABAB1ASA/GABAB2 receptors and endogenous 
GABAB receptors indicate normal trafficking 
capabilities of the mutant receptors.  
 However, transfection of neurons with 
GABAB1ASA/GABAB2ΔLZ receptors, which lack 
the CHOP interaction site in GABAB2, fully 
abolished the increased colocalization of GABAB1-
PDI (control: 13 ± 4 clusters, n=14; thapsigargin: 
10 ± 4 clusters, n=20, p > 0.05), GABAB2-PDI 
(control: 12 ± 5 clusters, n=14; thapsigargin: 9 ± 3 
clusters, n=11, p > 0.05) as well as GABAB1-
CHOP-PDI (control: 0.5 ± 1.1 clusters, n=15; 
thapsigargin: 1.5 ± 1.5 clusters, n=22, p > 0.05) 
and GABAB2-CHOP-PDI (control: 0.3 ± 0.8 
clusters, n=14; thapsigargin: 1.3 ± 1.2 clusters, 
n=12, p > 0.05; Fig. 5A, B) after induction of 
CHOP with thapsigargin. This result verified that 
CHOP directly interacts with GABAB receptors to 
induce their accumulation in the ER.  
 Because GABAB1 and GABAB2 interact via the 
leucine zippers in their C-terminal domains, 
binding of CHOP to GABAB2 may prevent 
GABAB receptor heterodimerization and thus 
inhibit forward trafficking of the receptors. 
Therefore, we tested whether up-regulation of 
CHOP interferes with heterodimerization of 
GABAB1 and GABAB2 using in situ PLA. In 
thapsigargin-treated neurons we observed a 
significant reduction of in situ PLA signals (64 ± 
5% of control, n=32, p < 0.001; Fig. 5C), 
indicating the presence of considerably less 
GABAB1/GABAB2 heterodimers as compared to 
untreated control neurons. This result suggests that 
interaction of CHOP with GABAB receptors 
disrupts or prevents heterodimerization of 
GABAB1 and GABAB2.  
 These findings suggest a mechanism, in which 
CHOP interacts with GABAB receptors in the ER 
after cellular stress to prevent heterodimerization 
of GABAB1 and GABAB2. Because only 
heterodimerized GABAB receptors can leave the 
ER (2-4), this mechanism is expected to impede 
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forward trafficking of newly synthesized receptors 
to the plasma membrane.  
 Up-regulation of CHOP Prevents Forward 
Trafficking of GABAB Receptors to the Cell 
Surface – To test whether up-regulation of CHOP 
impairs forward trafficking of GABAB receptors to 
the cell surface we transfected neurons with HA-
tagged GABAB2 and CHOP. Twenty-four hours 
after transfection newly synthetized HA-tagged 
receptors inserted into the plasma membrane were 
detected using an anti-HA antibody. In control 
neurons only transfected with HA-GABAB2 strong 
cell surface expression of HA-tagged GABAB2 was 
detected (Fig. 6A). However, in neurons 
transfected with CHOP staining for cell surface 
HA-GABAB2 was strongly reduced (36 ± 4% of 
control, n=25, p < 0.001; Fig. 6A). This reduction 
of cell surface HA-GABAB2 was not observed in 
neurons expressing a mutant of CHOP 
(CHOPLZ) that is unable to bind to GABAB2 (80 
± 7% of control, n=25, p > 0.05; Fig. 6A). These 
results suggest that the interaction of CHOP with 
GABAB2 impairs forward trafficking of GABAB 
receptors to the cell surface.  
 This result was confirmed for native GABAB 
receptors with an immunofluorescence-based 
forward trafficking assay using untreated control 
neurons and thapsigargin-treated neurons. After 
masking the existing receptor pool on the cell 
surface with primary and secondary antibodies, the 
insertion of new receptors into the plasma 
membrane was tested after 16 h. Membrane 
insertion of GABAB receptors was drastically 
reduced in neurons expressing high levels of 
CHOP (16 ± 6% of control, n=33, p < 0.001; Fig. 
6B).  
 Down-regulation of Cell Surface GABAB 
Receptors by CHOP in the OGD Model of 
Ischemia – Next we tested whether up-regulation 
of CHOP under ischemic conditions mediates 
down-regulation of cell surface GABAB receptors. 
We used the oxygen and glucose deprivation 
(OGD) in vitro model of ischemia, in which 
cultured cortical neurons were deprived for 10 min 
from oxygen and glucose followed by a recovery 
period of 24 h. 24 h after OGD, CHOP expression 
in neurons was significantly increased (157 ± 5% 
of control, n=311, p < 0.001; Fig. 7A). As expected, 
cell surface GABAB receptors considerably 
decreased 24 h after OGD in CHOP expressing 
neurons (44 ± 3% of control, n=49, p < 0.001; Fig. 
7B).  
 To test whether the interaction of CHOP with 
GABAB receptors is responsible for the down-
regulation of cell surface receptors after OGD, we 
overexpressed in cortical neurons CHOPΔLZ, a 
mutant form of CHOP that is not able to interact 
with GABAB2 and does not affect cell surface 
numbers of GABAB receptors (Fig. 1C). 
Endogenous CHOP was significantly up-regulated 
after OGD in transfected (154 ± 8% of control, 
n=20, p < 0.001) and in non-transfected neurons 
(167 ± 12% of control, n=22, p < 0.001; Fig. 8). In 
non-transfected neurons, GABAB2 receptors were 
down-regulated after OGD (60 ± 7% of control, 
n=27, p < 0.001; Fig. 8), whereas in neurons 
overexpressing CHOPΔLZ, despite similar up-
regulation of endogenous CHOP, the down-
regulation of GABAB receptors was completely 
prevented (113 ± 7% of control, n=45, p > 0.05; 
Fig. 8). These results verify that down-regulation 
of cell surface GABAB receptors after ischemic 
conditions is mediated by their interaction with 
CHOP.  
 
DISCUSSION  
 GABAB receptor-mediated neuronal inhibition 
critically depends on the availability of receptors 
in the plasma membrane. Receptor numbers might 
be altered under pathological conditions and a loss 
of receptors resulting in diminished neuronal 
inhibition is expected to contribute to the disease 
state. We previously showed that the ER stress-
induced transcription factor CHOP interacts with 
GABAB receptors, causing their down-regulation 
from the cell surface upon coexpression in HEK 
293 (22). This finding suggests that CHOP, 
besides its function as transcription factor, may 
regulate GABAB receptor-mediated neuronal 
inhibition by affecting the availability of cell 
surface receptors. Because CHOP is expressed at 
very low levels under normal physiological 
conditions but is highly up-regulated after 
induction of ER-stress (21,43-45), CHOP-induced 
down-regulation of cell surface GABAB receptors 
may be a contributing factor to neurological 
disease states associated with ER stress, such as 
stroke, Alzheimer’s and Parkinson’s disease or 
bipolar disorders (20).  
 In the present study, we verified that ER stress-
induced CHOP expression down-regulates cell 
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surface GABAB receptors also in neurons and 
disclosed the mechanism underlying this effect. An 
in vitro model of ischemia suggests that this 
mechanism is operative in cerebral ischemia.  
 We induced up-regulation of CHOP in cultured 
neurons by inhibition of the sarco/endoplasmic 
reticulum Ca
2+
-ATPase with thapsigargin, which 
leads to the depletion of Ca
2+
 from the ER thereby 
causing ER stress (46). Thapsigargin up-regulated 
CHOP in neurons and considerably down-
regulated GABAB receptors from the cell surface. 
The reduced level of cell surface receptors 
consequently affected downstream signaling of 
GABAB receptors as shown by impaired ERK1,2 
phosphorylation and reduced baclofen-induced 
inhibition of spontaneous neuronal activity.  
 Down-regulation of cell surface GABAB 
receptors was mediated by the interaction of the 
receptors with CHOP since overexpression in 
neurons of mutant forms either lacking the site 
binding to GABAB1 or the site binding to GABAB2 
prevented down-regulation of the receptors. Most 
importantly, up-regulation of CHOP did not affect 
the mRNA levels of GABAB1 and GABAB2, ruling 
out a contribution of impaired subunit transcription 
(Fig. 2D). 
 Up-regulated CHOP selectively accumulates 
together with GABAB receptors in the ER, 
suggesting that interaction with CHOP retains 
GABAB receptors in the ER and prevents their 
forward trafficking to the cell surface. This 
conclusion is supported by the finding that mutant 
GABAB receptors not containing the CHOP 
binding site in GABAB2 do not accumulate in the 
ER and that the insertion of new receptors into the 
plasma membrane is strongly reduced upon up-
regulation of CHOP. The mechanism that 
interferes with forward trafficking of the receptors 
appears to involve prevention or disruption of 
receptor heterodimerization as indicated by our in 
situ PLA experiments. It is currently not clear 
whether CHOP prevents heterodimerization of 
newly synthesized GABAB1 and GABAB2 by 
binding to GABAB1 and GABAB2 or directly 
disrupts already existing heterodimers. In either 
case, preventing heterodimerization exposes the 
ER retention signal in the C-terminal domain of 
GABAB1, which prohibits ER exit of GABAB1 (2-
4). In addition, GABAB2 contains a C-terminal 
sequence (amino acids 841-862) which is 
important for forward trafficking (47). Binding of 
CHOP to the leucine-zipper domain of GABAB2, 
upstream of this motif, might sterically interfere 
with the function of this motif and prevent ER 
export of GABAB2.  
 The mechanism of CHOP-induced down-
regulation of cell surface receptors appears to be 
operative under ischemic conditions. This is not 
surprising because cerebral ischemia has been 
shown to be associated with ER stress and the 
profound up-regulation of CHOP (35-42). Using 
the OGD in vitro model of ischemia, we found that 
up-regulated CHOP mediates down-regulation cell 
surface GABAB receptors, which depended on the 
interaction of CHOP with the receptors.  
 So far, the effect of cerebral ischemia on 
GABAB receptor expression levels has been rarely 
investigated and the results are difficult to 
correlate because different animal species and 
experimental conditions were used. In vivo models 
of ischemia demonstrated a loss of GABAB 
receptors 1-4 days after the insult (7-9). Because 
considerable ischemia-induced neuronal death 
occurs during this time period, the loss of GABAB 
receptors might be due, at least in part, to a loss of 
GABAB receptor expressing neurons. A recent in 
vitro study on cultured hippocampal slices using a 
similar OGD paradigm as in this study detected 
down-regulation of total GABAB2 but no effect on 
the expression of total GABAB1 (10). In the present 
study, we detected down-regulation of both 
GABAB1 and GABAB2 selectively from the cell 
surface but did not observe changes in total 
receptor expression. The reason for this 
discrepancy is not clear yet but it may be caused 
by different experimental conditions used 
(organotypic hippocampal slices, 45 min OGD 
versus cultured cortical neurons, 10 min OGD).  
Cerebral ischemia is associated with excessive 
glutamate release and overstimulation of glutamate 
receptors triggers a signaling cascade leading to 
neuronal death (48). The enhanced neuronal 
activity also increases extracellular levels of 
GABA (6), which in turn should activate GABAB 
receptors located at glutamatergic synapses to 
counteract, at least partially, the increased neuronal 
excitation to reduce excitotoxicity. The down-
regulation of functional GABAB receptors from the 
cell surface might therefore be one factor that 
fosters excitotoxicity. It is well established that 
sustained activation of GABAB receptors (by 
application of baclofen) under ischemic conditions 
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reduces neuronal cell death (10-19). In this regard, 
it is conceivable that restoring normal cell surface 
expression of GABAB receptors under ischemic 
conditions would also reduce excitotoxicity. This 
view is supported by a recent study showing that 
mild hypothermia reverses down-regulation of 
total GABAB1 after cerebral ischemia by an 
unknown mechanism and reduces neuronal death 
(8). 
 One opportunity to restore normal cell surface 
GABAB receptor levels would be the application of 
small synthetic peptides interfering with the 
CHOP-GABAB receptor interaction. Further 
experiments are required to identify small peptide 
sequences that inhibit the interaction of CHOP 
with GABAB receptors but do not interfere with 
receptor heterodimerization. This approach 
provides the opportunity to unambiguously test the 
hypothesis whether CHOP-induced down-
regulation of cell surface GABAB receptors 
promotes excitotoxicity. If this is the case small 
interfering peptides may be of potential therapeutic 
use to limit neuronal death under ischemic 
conditions. Such an intervention would be highly 
specific because CHOP is significantly expressed 
only upon ER stress and it targets a specific 
protein-protein interaction in response to the 
ischemic insult and is thus expected to be 
associated with low risk of side effects. 
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FIGURE LEGENDS 
 
Figure 1. Up-regulated CHOP interacts with GABAB receptors in neurons. 
A, CHOP over-expressed in neurons interact with GABAB receptors. Cortical neurons were left non-
tranfected (-CHOP) or were transfected with CHOP (+CHOP) and analyzed for interaction with GABAB 
receptors by in situ PLA using antibodies directed against CHOP and GABAB2. Because under normal 
physiological conditions CHOP expression is low, only few interactions (white dots in representative 
images) were detected. However, overexpression of CHOP resulted in numerous CHOP-GABAB receptor 
interactions. The images represent merged Z-stack reconstructions of 5 optical section spaced by 0.4 m. 
Scale bar: 5 m. 
B, Thapsigargin-induced CHOP interacts with GABAB receptors. Cortical neurons were incubated with 2 
μM thapsigargin for 2 h and were allowed to recover in their original culture medium for 16 h. The 
interaction of CHOP with GABAB receptors was determined by in situ PLA using antibodies directed 
against CHOP and GABAB2 (white dots in representative images, left; scale bar: 5 m). Right: 
quantification of in situ PLA signals. Means ± S.E.M., 30 neurons from four experiments. ***, p<0.001, t-
test.  
C, CHOP does not interact with GABAA receptors. Cortical neurons were treated (TG) or not (Ctrl) with 2 
g thapsigargin for 2 h and were allowed to recover in their original culture medium for 16 h. The 
interaction of CHOP with GABAA receptors was determined by in situ PLA using antibodies directed 
against CHOP and the 1 subunit of GABAA receptors. No interactions were observed (right panels). As a 
positive control, the interaction of the GABAA receptor subunits 1 and 2/3 was tested. Numerous 
interactions were detected in untreated neurons (white dots in representative image, left panel). The 
images represent merged Z-stack reconstructions of 5 optical section spaced by 0.4 m. Scale bar: 5 m. 
 
Figure 2. Up-regulated CHOP in neurons mediate down-regulation of cell surface GABAB receptors. 
A, Up-regulation of CHOP down-regulates cell surface GABAB receptors. Neurons were treated with 
thapsigargin and stained for surface GABAB1 and GABAB2 (green). Subsequently cells were fixed, 
permeabilized and stained for CHOP (red). Neurons not treated with thapsigargin served as controls. Left: 
representative images; scale bar: 7 m. Right: quantification of cell surface GABAB1, GABAB2 and CHOP. 
Means ± S.E.M., 50-55 neurons from five experiments. ***, p<0.001, t-test.  
A, Up-regulation of CHOP does not affect total GABAB receptor expression levels. Neurons were treated 
with thapsigargin and stained for total GABAB1 and GABAB2 (green) and CHOP (red). Neurons not 
treated with thapsigargin served as controls (Ctrl). Scale bar: 10 m. Bar graphs show quantification of 
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total expression levels of GABAB1 and GABAB2. Means ± S.E.M., 30 neurons from three experiments. n.s., 
p>0.05, t-test.  
C, Mutant forms of CHOP that cannot bind to GABAB receptors do not mediate down-regulation of cell 
surface receptors. Neurons were cotransfected with EGFP and CHOP or mutant forms of CHOP lacking 
its interaction site with GABAB2 (CHOPΔLZ) or its interaction site with GABAB1 (CHOPΔN). After 48 h, 
transfected neurons were stained for cell surface GABAB2 (green) and for CHOP (red). Left: 
representative images; scale bar: 10 m. Right: quantification of cell surface GABAB2 levels in neurons 
expressing either CHOP, CHOPΔLZ or CHOPΔN. Means ± S.E.M., 82 (EGFP and CHOP), 79 
(CHOPΔLZ) and 101 (CHOPΔN) neurons from three experiments. ***, p<0.001, one way ANOVA, 
Bonferroni's multiple comparison test.  
D, CHOP does not regulate GABAB receptor mRNA levels. Total mRNA was isolated from neuronal 
cultures treated or not treated (controls) with thapsigargin. CHOP, GABAB1 and GABAB2 mRNA was 
quantified using real-time PCR. Means ± S.E.M., 4 (CHOP) and 5 (GABAB1 and GABAB2) individual 
cultures were analyzed. ***, p<0.001, n.s.: not significant (p>0.05), t-test.  
 
Figure 3. CHOP-mediated down-regulation of cell surface GABAB receptors impairs GABAB 
receptor-mediated downstream signaling. 
A, GABAB receptor-induced phosphorylation of ERK1/2 was prevented by the GABAB receptor antagonist 
CPG 56999A and by thapsigargin-induced up-regulation of CHOP. Neurons were treated with 
thapsigargin (+TG) to upregulate CHOP while control cultures remained untreated. Subsequently, neurons 
were incubated for 10 min with 100 μM baclofen in the presence or absence of 10 μM CPG 56999A 
(+CGP, GABAB receptor antagonist). After fixation and permeabilization neurons were stained for total 
ERK1/2 (ERK, green) and diphosphorylated ERK1/2 (pERK, red). Left: representative images; scale bar: 5 
m. Right: quantification of pERK levels. Means ± S.E.M., 26 (baclofen, baclofen + CPG) and 28 
(baclofen + TG) neurons from three experiments. ***, p<0.001, one way ANOVA, Bonferroni's multiple 
comparison test.  
B, Up-regulation of CHOP diminished baclofen-induced inhibition of spontaneous postsynaptic currents 
(sPSCs). Left: Representative current traces depicting spontaneous sPSCs recorded from untreated control 
neurons (n=9) or from neurons treated with thapsigargin for up-regulation of CHOP (n=5). Right: 
Normalized amplitude and frequency values of the sPSCs. Mean amplitudes and frequency values were 
normalized to the control condition of the individual neuron. Con.: control, bac.: baclofen, TG.: 
thapsigargin. Mean ± S.E.M., *, p < 0.05, t-test. 
 
Figure 4. Up-regulated CHOP colocalize with GABAB receptors in the ER and induces their 
intracellular accumulation. 
A, B, GABAB receptors accumulate in the ER and colocalize with CHOP. Neurons were treated with 
thapsigargin to upregulate CHOP and stained for GABAB1 (A) or GABAB2 (B) (green), CHOP (red) and 
the ER marker PDI (blue). Cultures not treated with thapsigargin served as controls. Left: representative 
images depicting GABAB1/B2-CHOP-PDI colocalization (white dots marked with arrows, scale bar: 5 m). 
Right: quantification of colocalization. Means ± S.D., 20-32 neurons per colocalization from three 
experiments. ***, p<0.001, t-test.  
C, GABAB receptors do not accumulate or colocalize with CHOP in the Golgi apparatus. Neurons were 
treated with thapsigargin to upregulate CHOP and stained for GABAB2 (green), CHOP (red) and the Golgi 
marker GM130 (blue). Cultures not treated with thapsigargin served as controls. Left: representative 
images, scale bar: 5 m. Right: quantification of colocalization. Means ± S.D., 19 neurons per 
colocalization from three experiments. n.s.: not significant (p>0.05), t-test.  
D, GABAB receptors do not colocalize with CHOP on the cell surface. Neurons were treated with 
thapsigargin to upregulate CHOP and were then stained for cell surface GABAB2 (green) as well as for 
CHOP (red). Cultures not treated with thapsigargin served as controls. Left: representative images, scale 
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bar: 5 m. Right: quantification of colocalization. Means ± S.D., 44 (control) and 45 (thapsigargin) 
neurons from four experiments. n.s.: not significant (p>0.05), t-test.  
 
Figure 5. Accumulation of GABAB receptors in the ER is mediated by interaction with CHOP. 
A, B, Neurons were transfected with EGFP in combination with GABAB1ASA/GABAB2 or 
GABAB1ASA/GABAB2ΔLZ. After 48h, neurons were treated with thapsigargin to upregulate CHOP and 
then stained for GABAB1ASA (A) or GABAB2ΔLZ (B), CHOP and the ER marker PDI. Cultures not 
treated with thapsigargin served as controls. Left: representative images depicting colocalization of 
GABAB1-CHOP-PDI and GABAB2-CHOP-PDI (white dots, scale bar: 5 m). Right: quantification of 
colocalization. Means ± S.D., 11-22 neurons per colocalization from two experiments. **, p<0.01;***, 
p<0.001, n.s.: not significant (p>0.05), t-test.  
C, Up-regulation of CHOP interferes with GABAB receptor heterodimerization. Neurons were treated with 
thapsigargin to upregulate CHOP and tested for GABAB1/GABAB2 heterodimerization by in situ PLA 
using antibodies directed against GABAB1 and GABAB2 (white dots in representative images, left; scale 
bar: 5 m). Cultures not treated with thapsigargin served as controls. The images represent merged Z-
stack reconstructions of 5 optical section spaced by 0.4 m. Right: quantification of in situ PLA signals. 
Means ± S.E.M., 32 neurons from three experiments. ***, p<0.001, t-test. 
 
Figure 6. Up-regulated CHOP impairs forward trafficking of GABAB receptors.  
A, Neurons were transfected with either EGFP and HA-tagged GABAB2 (control), EGFP, HA-GABAB2 
and CHOP (Chop) or EGFP HA-GABAB2 and CHOPLZ (CHOPLZ). Twenty-four hours after 
transfection, GABAB receptors newly inserted into the plasma membrane were visualized by staining with 
HA-antibodies. Left: representative images, scale bar: 5 m. Right: quantification of GABAB receptor 
membrane insertion. Means ± S.E.M., 25 neurons per condition from three experiments. ***, p<0.001, 
one way ANOVA, Dunnett’s post-hoc test. 
B, Neurons were treated with thapsigargin to upregulate CHOP und subjected to an immunofluorescence-
based forward trafficking assay to determine the amounts of GABAB receptors inserted into the plasma 
membrane within a time period of 16 h (red clusters in representative images, scale bar: 5 m). CHOP 
expression is depicted in blue. Cultures not treated with thapsigargin served as controls. Right: 
quantification of GABAB receptor membrane insertion. Means ± S.E.M., 38 (control) and 33 
(thapsigargin) neurons from three experiments. ***, p<0.001, t-test. 
 
Figure 7. CHOP is up-regulated and GABAB receptors are down-regulated in the OGD model of 
cerebral ischemia.  
A, Oxygen and glucose deprivation (OGD) in neurons upregulates CHOP. Neurons were subjected to 
OGD for 10 min, followed by a recovery period of 24 h. Subsequently, neurons were stained for CHOP 
(green) and for NeuN to visualize the neurons (red). CHOP expression in neurons is depicted in yellow. 
Cultures not subjected to OGD served as controls. Left: representative images, scale bar: 30 m. Right: 
quantification of CHOP expression in neurons. Means ± S.E.M., 271 (control) and 311 (thapsigargin) 
neurons from three experiments. ***, p<0.001, t-test. 
B, Cell surface GABAB receptors are down-regulated following OGD. Neurons were subjected to OGD 
for 10 min, followed by a recovery period of 24 h and were then stained for cell surface GABAB2 (green) 
and CHOP (red). Cultures not subjected to OGD served as controls. Left: representative images, scale bar: 
5 m. Right: quantification of cell surface GABAB receptor expression. Means ± S.E.M., 30 (control) and 
49 (thapsigargin) neurons from three experiments. ***, p<0.001, t-test. 
 
Figure 8. Interaction of CHOP with GABAB receptors is responsible for OGD-induced down-
regulation of cell surface receptors.  
Neurons were transfected with a CHOP mutant that is not able to interact with GABAB2 (CHOPΔLZ) and 
EGFP. After 24 h, neurons were subjected to OGD for 10 min, followed by a recovery period of 24 h. 
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Subsequently, neurons were stained for cell surface GABAB receptors (blue) and endogenous CHOP (red). 
CHOPΔLZ overexpressing neurons were selected by means of EGFP expression. Cultures not subjected to 
OGD served as controls. Top: representative images, scale bar: 5 m. Bottom: quantification of cell 
surface GABAB receptors. Means ± S.E.M., 38 (control, non-transfected), 27 (OGD, non-transfected), 36 
(control, transfected) and 45 (OGD, transfected) neurons from three experiments. **, p<0.01, n.s.: not 
significant (p>0.05), t-test.  
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